The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV
Official Title: Screening HIV-Infected Women for Anal Cancer Precursors
Study ID: NCT01946139
Brief Summary: This clinical trial studies anal human papillomavirus (HPV) tests in screening for cell changes in the anus in patients with human immunodeficiency virus (HIV). Screening tests may help doctors find cancer cells early and plan better treatment for anal cancer. Completing multiple screening tests may help find the best method for detecting cell changes in the anus.
Detailed Description: PRIMARY OBJECTIVES: I. To determine the sensitivity and specificity of HPV testing using different methods of detection, including HPV Hybrid Capture 2 (HC2), HPV messenger ribonucleic acid (mRNA) assays (APTIMA) and OncoHealth HPV E6/E7 oncoprotein assay and whether they improve the screening performance of routine anal cytology for the detection of anal high-grade squamous intraepithelial lesions (HSIL) when measured against the gold standard, biopsy-proven HSIL. II. To determine the prevalence and risk factors for prevalent HSIL in HIV-infected women. III. To determine incidence and risk factors associated with anal HSIL and HPV over 2 years among HIV infected women undergoing semi-annual anal evaluations. EXPLORATORY OBJECTIVES: I. To evaluate the acceptability of anal cancer screening among HIV-infected women. II. To collect data on quality of life and health care costs (including non-direct health care costs and time costs) for an economic evaluation of the cost-effectiveness of anal cancer screening strategies in HIV-positive women. OUTLINE: Patients undergo screening for the detection of HSIL using anal cytology, HPV hybrid capture 2, HPV mRNA assays, and OncoHealth HPVE6/E7 oncoprotein at baseline, at 12 and 24 months.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
UCLA Clinical AIDS Research and Education (CARE) Center, Los Angeles, California, United States
Ucsf Ancre, San Francisco, California, United States
John H. Stroger Hospital of Cook County, Chicago, Illinois, United States
Boston University Cancer Research Center, Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Montefiore Medical Center, Bronx, New York, United States
Weill-Cornell Medical College, New York, New York, United States
Laser Surgery Care Center, New York, New York, United States
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States
Baylor College of Medicine, Houston, Texas, United States
University of Puerto Rico Comprehensive Cancer Center, San Juan, , Puerto Rico
Name: Elizabeth Chiao
Affiliation: AIDS Associated Malignancies Clinical Trials Consortium
Role: PRINCIPAL_INVESTIGATOR